Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is $3,165.53, with a 24-hour trading volume of $40.42B. The asset's market cap is $7.85T, after moving -1.35% in the last day.
Tokenized Merck & Co Inc is trading at $3,299.34, with a tokenized market cap of $24.74M and a 24-hour trading volume of $87.17K. The tokenized asset has moved 2.64% in the past 24 hours.